ASX
Argenica Therapeutics Limited
AGN:ASX•Healthcare
Sensitive ASX Announcement
First Healthy Adult Subject Dosed in Phase 1 Trial of ARG007
Published: 17/10/22, 09:34am (AEST)•1 pages